Literature DB >> 30691871

Is R1 vascular hepatectomy for hepatocellular carcinoma oncologically adequate? Analysis of 327 consecutive patients.

Matteo Donadon1, Alfonso Terrone2, Fabio Procopio2, Matteo Cimino2, Angela Palmisano2, Luca Viganò1, Daniele Del Fabbro2, Luca Di Tommaso3, Guido Torzilli4.   

Abstract

BACKGROUND: R1 vascular resection for liver tumors was introduced in the early twenty-first century. However, its oncologic adequacy remains controversial. The aim of this study was to determine the oncologic adequacy of R1 vascular hepatectomy in hepatocellular carcinoma patients.
METHODS: A prospective cohort of patients with hepatocellular carcinoma resected between the years 2005 and 2015 was reviewed. R0 was any resection with a minimum 1 mm of negative margin. R1 vascular was any resection with tumor exposure attributable to the detachment from major intrahepatic vessel. R1 parenchymal was any resection with tumor exposure at parenchymal margin. The end points were the calculation of the local recurrence of R0, R1 parenchymal, and R1 vascular hepatectomy and their prognostic significances.
RESULTS: We analyzed 327 consecutive patients with 532 hepatocellular carcinoma and 448 resection areas. We found that 205 (63%) resulted R0, 56 (17%) resulted R1 parenchymal, 50 (15%) resulted R1 vascular, and 16 (5%) resulted both R1 parenchymal and R1 vascular. After a median follow-up of 33.5 months (range 6.1-107.6), the 5-year overall survival rates were 54%, 30%, 65%, and 36%, respectively for R0, R1 parenchymal, R1 vascular, and R1 parenchymal + R1 vascular (P = .031). Local recurrence rates were 3%, 14%, 4%, and 19%, respectively for R0, R1 parenchymal, R1 vascular, and R1 parenchymal + R1 vascular (P = .001) per patient, and 4%, 4%, 12%, and 18%, respectively for R0, R1 vascular, R1 parenchymal, and R1 parenchymal + R1 vascular (P = .001) per resection area. At multivariate analysis R1 parenchymal and R1 vascular + R1 parenchymal were independent detrimental factors.
CONCLUSION: R1 vascular hepatectomy for hepatocellular carcinoma is not associated with increased local recurrence or decreased survival. Thus, detachment of hepatocellular carcinoma from intrahepatic vessels should be considered oncologically adequate.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30691871     DOI: 10.1016/j.surg.2018.12.002

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  8 in total

1.  ASO Author Reflections: Laparoscopic R1 Vascular Hepatectomy for Hepatocellular Carcinoma: A Step Forward.

Authors:  Annarita Libia; Valentina Ferraro; Riccardo Memeo
Journal:  Ann Surg Oncol       Date:  2021-02-20       Impact factor: 5.344

2.  Laparoscopic R1 Vascular Hepatectomy for Hepatocellular Carcinoma (with Video).

Authors:  Annarita Libia; Valentina Ferraro; Michele Tedeschi; Nicola de'Angelis; Guido Torzilli; Luca Aldrighetti; Patrick Pessaux; Daniel Cherqui; Riccardo Memeo
Journal:  Ann Surg Oncol       Date:  2021-02-05       Impact factor: 5.344

Review 3.  [Surgical treatment of hepatic tumors-liver resection and transplantation].

Authors:  H Lang; S Heinrich; F Bartsch; F Hüttl; J Baumgart; J Mittler
Journal:  Internist (Berl)       Date:  2020-02       Impact factor: 0.743

4.  Parenchyma-sparing vessel-guided major hepatectomies: Nonsense or new paradigm?

Authors:  Guido Torzilli
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2021-06-30

5.  Impact on Oncological Outcomes and Intent-to-Treat Survival of Resection Margin for Transplantable Hepatocellular Carcinoma in All-Comers and in Patients with Cirrhosis: A Multicenter Study.

Authors:  Chetana Lim; Claire Goumard; Margarida Casellas-Robert; Santiago Lopez-Ben; Laura Lladó; Juli Busquets; Chady Salloum; Maria Teresa Albiol-Quer; Ernest Castro-Gutiérrez; Olivier Rosmorduc; Cyrille Feray; Emilio Ramos; Joan Figueras; Olivier Scatton; Daniel Azoulay
Journal:  World J Surg       Date:  2020-06       Impact factor: 3.352

6.  Minimal access liver surgery: from the escalation, to the boundaries, searching for the rules.

Authors:  Guido Torzilli
Journal:  Hepatobiliary Surg Nutr       Date:  2019-12       Impact factor: 7.293

7.  Placement of vein grafting in liver surgery at the time of the R1 vascular concept and the communicating veins.

Authors:  Guido Torzilli
Journal:  Hepatobiliary Surg Nutr       Date:  2022-08       Impact factor: 8.265

8.  Combined Liver and Inferior Vena Cava Resection for Malignancies Is Safe and Feasible in a Group of High-Risk Patients.

Authors:  Sandra Schipper; Markus Zimmermann; Andreas Kroh; Ulf Peter Neumann; Tom Florian Ulmer
Journal:  J Clin Med       Date:  2020-04-12       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.